{"id":17952,"date":"2026-06-01T05:10:23","date_gmt":"2026-06-01T08:10:23","guid":{"rendered":"https:\/\/rtmedical.com.br\/tmp-en-1780301423102\/"},"modified":"2026-06-01T05:10:29","modified_gmt":"2026-06-01T08:10:29","slug":"ai-mammography-low-risk-triage","status":"publish","type":"post","link":"https:\/\/rtmedical.com.br\/en\/ai-mammography-low-risk-triage\/","title":{"rendered":"AI Could Cut 77% of Mammograms From Double Reading"},"content":{"rendered":"

A new French study delivered a figure that should make any imaging-service manager pause: artificial intelligence flagged 77% of mammography exams as low-risk<\/strong>, cases that could safely be pulled out of the double-reading workflow. In practice, that means lifting three out of every four exams off a second radiologist’s desk and concentrating expert time where it truly counts.<\/p>\n

\"Screening
AI flags low-risk exams and helps redistribute the effort spent on double reading.<\/figcaption><\/figure>\n

What the study found<\/h2>\n

The research, published in Radiology: Artificial Intelligence<\/em>, retrospectively analyzed mammograms from roughly 42,400 women acquired between 2015 and 2019. Investigators ran Therapixel’s MammoScreen<\/strong> algorithm and compared its performance against standard radiologist double reading.<\/p>\n

France’s screening paradigm is unusual, and it helps explain the impact. Unlike the rest of Europe, France reserves double reading only for the lowest-risk cases \u2014 those classified BI-RADS 1 and 2 \u2014 while BI-RADS 3 to 5 exams go straight to diagnostic workup. Because double reading falls precisely on exams with low cancer prevalence, spotting the rare tumors hiding there is especially hard. The study asked a blunt question: what if AI took over that low-risk triage?<\/p>\n

The numbers behind the triage<\/h2>\n

By classifying 77% of exams as low-risk, the model let only one cancer slip through<\/strong> in that group \u2014 a rate the researchers called “small but measurable.” Eleven additional cancers turned up in the group AI labeled non-low-risk, exams that would have gone through double reading anyway under the new workflow.<\/p>\n

The most telling figure may be interval cancer \u2014 the kind that surfaces between screening rounds. Its rate was five times higher<\/strong> in cases classified non-low-risk than in low-risk ones (2.16 versus 0.47 per 1,000 exams). That signals the algorithm wasn’t guessing: it genuinely separated exams with biologically distinct risk profiles.<\/p>\n

Why it matters for clinical practice<\/h2>\n

Double reading is expensive and consumes a scarce resource: radiologists. Removing 77% of exams from that step redirects skilled hours toward complex cases \u2014 exactly the ones that benefit most from careful human eyes. In systems strained by staffing shortages the payoff is obvious; recall how much public services already spend covering that gap, as we covered in the NHS’s billion-dollar radiology shortfall<\/a>.<\/p>\n

Even so, the study doesn’t hide the trade-off. There is a “small but non-zero risk” of missing a cancer. No manager should adopt AI triage without clear governance: continuous performance monitoring, auditing of low-risk cases, and fallback protocols. The technology shifts human effort \u2014 it does not erase clinical accountability.<\/p>\n

Context: the mammography AI race<\/h2>\n

This result doesn’t stand alone. It echoes a wave of recent research testing AI as a screening filter, especially in Europe, where the double-reading paradigm magnifies the potential savings. Vision-language models are advancing on the same terrain \u2014 it’s worth knowing about HOPPR’s vision-language model for mammography<\/a>, which points toward increasingly machine-assisted reporting.<\/p>\n

The underlying debate stays the same one shadowing the whole specialty: does AI replace or support the radiologist? The evidence keeps pointing to support. As we discussed when analyzing whether AI helps trainees more than specialists<\/a>, the real gain shows up when the machine takes the repetitive work and the human keeps the hard judgment calls.<\/p>\n

How double reading works \u2014 and the Latin American angle<\/h2>\n

It’s worth spelling out the concept for anyone outside breast screening. In double reading, two radiologists analyze the same exam independently; when they disagree, a third arbitrates or the case goes to additional imaging. The method raises sensitivity and reduces missed cancers, but it costs twice the radiologist-hours per exam \u2014 a luxury that is increasingly hard to sustain.<\/p>\n

In much of Latin America the picture differs from Europe’s: a large share of screening is single-read and often opportunistic, performed when a woman visits a service for another reason. That changes the calculus of AI triage. Rather than replacing a second read that frequently doesn’t exist, AI here tends to act as a safety net \u2014 flagging suspicious findings in services with few specialists and long queues. The lesson from the French study still holds: AI is effective at separating exams by risk, and that capability can be tuned to very different realities of coverage and radiologist density.<\/p>\n

There is also the opportunistic-radiology and structured-reporting angle. When AI triage is wired into the PACS and the reporting system, it becomes simpler to track performance by cohort, audit false negatives, and adjust the “low-risk” threshold to local prevalence \u2014 exactly the governance that turns a strong research metric into routine safety.<\/p>\n

Outlook and limitations<\/h2>\n

Because it is retrospective and built around a screening paradigm specific to France, the study needs prospective validation \u2014 and testing in other screening systems \u2014 before it becomes routine. Still, the message is consistent with the literature: AI retains its ability to reduce radiologist workload across different breast cancer screening programs. The next steps involve controlled trials, integration into PACS and structured-reporting workflows, and clear audit rules, so that resource savings never come at the cost of a missed diagnosis.<\/p>\n

Source:<\/strong> The Imaging Wire \u2014 “AI Reduces Mammography Workload”<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

A French study shows AI flagged 77% of mammograms as low-risk, freeing radiologists from double reading without losing accuracy.<\/p>\n","protected":false},"author":1,"featured_media":17948,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ngg_post_thumbnail":0,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[102,100],"tags":[],"class_list":{"0":"post-17952","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ai","8":"category-radiology"},"aioseo_notices":[],"rt_seo":{"title":"","description":"AI flagged 77% of mammograms as low-risk and cut double reading without losing accuracy. See the numbers from the French study.","canonical":"","og_image":"","robots":"index,follow","schema_type":"Article","include_in_llms":true,"llms_label":"AI mammography triage","llms_summary":"French study using MammoScreen (Therapixel) on 42,400 women: AI classified 77% of mammograms as low-risk, removing them from double reading with a small but non-zero miss risk.","faq_items":[],"video":[],"gtin":"","mpn":"","brand":"","aggregate_rating":[]},"_links":{"self":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/17952\/"}],"collection":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/"}],"about":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/types\/post\/"}],"author":[{"embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/users\/1\/"}],"replies":[{"embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/comments\/?post=17952"}],"version-history":[{"count":1,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/17952\/revisions\/"}],"predecessor-version":[{"id":17954,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/17952\/revisions\/17954\/"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/media\/17948\/"}],"wp:attachment":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/media\/?parent=17952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/categories\/?post=17952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/tags\/?post=17952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}